GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Biotherapeutics Inc (FRA:PSH0) » Definitions » YoY EPS Growth

Sernova Biotherapeutics (FRA:PSH0) YoY EPS Growth : 38.10% (As of Jan. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Sernova Biotherapeutics YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Sernova Biotherapeutics's YoY EPS Growth for the quarter that ended in Jan. 2025 was 38.10%.

Sernova Biotherapeutics's Earnings per Share (Diluted) for the three months ended in Jan. 2025 was €-0.01.


Sernova Biotherapeutics YoY EPS Growth Historical Data

The historical data trend for Sernova Biotherapeutics's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Biotherapeutics YoY EPS Growth Chart

Sernova Biotherapeutics Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -35.71 -10.53 -219.05 -34.33 25.56

Sernova Biotherapeutics Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 38.10 75.00 38.10

Sernova Biotherapeutics YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Sernova Biotherapeutics's YoY EPS Growth for the fiscal year that ended in Oct. 2024 is calculated as:

YoY EPS Growth (A: Oct. 2024 )
=(Earnings per Share (Diluted) (A: Oct. 2024 )-Earnings per Share (Diluted) (A: Oct. 2023 ))/ | Earnings per Share (Diluted) (A: Oct. 2023 ) |
=(-0.067--0.09)/ | -0.09 |
=25.56 %

Sernova Biotherapeutics's YoY EPS Growth for the quarter that ended in Jan. 2025 is calculated as:

YoY EPS Growth (Q: Jan. 2025 )
=(Earnings per Share (Diluted) (Q: Jan. 2025 )-Earnings per Share (Diluted) (Q: Jan. 2024 )) / | Earnings per Share (Diluted) (Q: Jan. 2024 )) |
=(-0.013--0.021)/ | -0.021 |
=38.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sernova Biotherapeutics YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Sernova Biotherapeutics's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Sernova Biotherapeutics Business Description

Traded in Other Exchanges
Address
700 Collip Circle, Suite 114, London, ON, CAN, N6G 4X8
Sernova Biotherapeutics Inc is a clinical-stage company developing regenerative medicines. The company develops Cell Pouch with human donor cells or stem cells to create a biohybrid organ. The Cell Pouch is a implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones, or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.

Sernova Biotherapeutics Headlines

No Headlines